Hong Kong Stock Market Announcement Insights | Johnson Matthey Group Announces Profit Surprise Expecting Net Profit Exceeding HKD 4.32 Billion by 2025, Up Over 165% Year-on-Year
Xuanzhu Biological-B (02575) included in the Hang Seng Composite Index constituents
Weishi Holdings (03393) included in the Hang Seng Composite Index constituents
Xiehe New Energy (00182) subsidiary plans to purchase approximately $56.61 million worth of energy storage equipment
Cornerstone Pharmaceutical-B (02616): Sogrolimab Phase III treatment for small cell lung cancer receives approval from the UK MHRA
HeBo Medicine-B (02142) enters into exclusive licensing agreement and equity cooperation agreement with Solstice Oncology regarding HBM4003
Operational Performance:
Jiantao Group (00148) issues profit warning, expects net profit for 2025 to exceed HKD 4.32 billion, an increase of over 165% year-on-year
Honghui Group (00183) issues profit warning, expects interim attributable loss to shareholders to decrease significantly by 30% to 40%
Jiantao Modular Boards (01888) issues profit warning, expects net profit for 2025 to exceed HKD 2.39 billion, an increase of over 80% year-on-year
Leco Technology International (00195) issues profit warning, expects interim attributable profit to shareholders to be no less than HKD 60 million
Denghui Holdings (01692) issues profit warning, expects annual attributable profit to shareholders to be approximately HKD 57 million to HKD 68 million, a decrease year-on-year
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hong Kong Stock Market Announcement Insights | Johnson Matthey Group Announces Profit Surprise Expecting Net Profit Exceeding HKD 4.32 Billion by 2025, Up Over 165% Year-on-Year
Major Events:
Xuanzhu Biological-B (02575) included in the Hang Seng Composite Index constituents
Weishi Holdings (03393) included in the Hang Seng Composite Index constituents
Xiehe New Energy (00182) subsidiary plans to purchase approximately $56.61 million worth of energy storage equipment
Cornerstone Pharmaceutical-B (02616): Sogrolimab Phase III treatment for small cell lung cancer receives approval from the UK MHRA
HeBo Medicine-B (02142) enters into exclusive licensing agreement and equity cooperation agreement with Solstice Oncology regarding HBM4003
Operational Performance:
Jiantao Group (00148) issues profit warning, expects net profit for 2025 to exceed HKD 4.32 billion, an increase of over 165% year-on-year
Honghui Group (00183) issues profit warning, expects interim attributable loss to shareholders to decrease significantly by 30% to 40%
Jiantao Modular Boards (01888) issues profit warning, expects net profit for 2025 to exceed HKD 2.39 billion, an increase of over 80% year-on-year
Leco Technology International (00195) issues profit warning, expects interim attributable profit to shareholders to be no less than HKD 60 million
Denghui Holdings (01692) issues profit warning, expects annual attributable profit to shareholders to be approximately HKD 57 million to HKD 68 million, a decrease year-on-year